Echo Therapeutics Data “Thrills,” and NanoViricides Targets Flu Virus
I need to update you on several events I told you were coming. First, NanoViricides Inc. leadership has chosen their victim -- the influenza virus family. I'll have more on that in a bit. First, I have news regarding clinical trials of the noninvasive, wireless transdermal continuous glucose monitoring (tCGM) system developed by Echo Therapeutics Inc.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Breakthrough Technology Alert
This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.